Working… Menu

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02157714
Recruitment Status : Completed
First Posted : June 6, 2014
Last Update Posted : October 21, 2016
Hoffmann-La Roche
Information provided by (Responsible Party):
Prothena Biosciences Limited